Breakthrough discoveries and unprecedented capital funding have heightened the dynamic nature of the life sciences industry. This surge of resources should fuel a new level of growth in research & development (R&D) and accelerate the demand for quality manufacturing space.
With additional trends like onshoring of manufacturing production, localized manufacturing and surging demand from emerging biotechnology and large pharmaceutical companies alike, there is intense interest from the life science and real estate industries in facilities that are suitable for these good manufacturing practice (GMP) requirements.
